抗心律失常药物：临床药理学与治疗用途 - Suppr

Suppr

超能文献

Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

作者信息

Anderson J L, Harrison D C, Meffin P J, Winkle R A

出版信息

Drugs. 1978 Apr;15(4):271-309. doi: 10.2165/00003495-197815040-00003.

DOI:10.2165/00003495-197815040-00003

PMID:648399

Abstract

摘要

相似文献

Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.抗心律失常药物：临床药理学与治疗用途

Drugs. 1978 Apr;15(4):271-309. doi: 10.2165/00003495-197815040-00003.

Drugs and the heart. IV. Antiarrhythmic agents.药物与心脏。IV. 抗心律失常药物。

Lancet. 1980 Apr 19;1(8173):861-8. doi: 10.1016/s0140-6736(80)91364-1.

Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.抗心律失常药物的临床药理学：综述与概述，第二部分

Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):185-99.

Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.老年人的心律失常：抗心律失常药物治疗

Cardiol Clin. 1986 May;4(2):285-303.

Antiarrhythmic drug therapy.抗心律失常药物治疗

Am J Nurs. 1980 Jul;80(7):1288-95.

Prevention of sudden coronary death by chronic antiarrhythmic therapy.通过长期抗心律失常治疗预防心源性猝死。

Adv Cardiol. 1978;25:206-28. doi: 10.1159/000402022.

Clinical pharmacokinetics of antiarrhythmic drugs.

Prog Cardiovasc Dis. 1977 Nov-Dec;20(3):217-42. doi: 10.1016/0033-0620(77)90022-6.

[Current anti-arrhythmic treatments and drugs].[当前的抗心律失常治疗方法与药物]

Coeur Med Interne. 1973 Jan-Mar;12(1):129-44.

Antiarrhythmic drug therapy of ventricular arrhythmias.室性心律失常的抗心律失常药物治疗。

Curr Probl Cardiol. 1986 Apr;11(4):177-240. doi: 10.1016/0146-2806(86)90016-2.

[Drug therapy of tachyarrhythmias (author's transl)].快速性心律失常的药物治疗（作者译）

Klin Wochenschr. 1978 Feb 15;56(4):153-68. doi: 10.1007/BF01705379.

引用本文的文献

Adverse effects of antiarrhythmic drugs.抗心律失常药物的不良反应。

Drugs. 1981 Jan;21(1):23-45. doi: 10.2165/00003495-198121010-00002.

The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias.控释磷酸丙吡胺和长效普萘洛尔对室性心律失常患者的抗心律失常作用。

Eur J Clin Pharmacol. 1983;25(6):729-34. doi: 10.1007/BF00542510.

Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.疑似急性心肌梗死时室性心律失常的预防：妥卡尼与丙吡胺的比较

Br J Clin Pharmacol. 1984 Nov;18(5):725-32. doi: 10.1111/j.1365-2125.1984.tb02535.x.

Reliability of antiarrhythmic drug plasma concentration monitoring.抗心律失常药物血药浓度监测的可靠性

Clin Pharmacokinet. 1983 Jan-Feb;8(1):63-82. doi: 10.2165/00003088-198308010-00004.

[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].新型抗心律失常药物的电生理分类（作者译）

Klin Wochenschr. 1980 Sep 15;58(18):907-18. doi: 10.1007/BF01477048.

Clinical relevance of pharmacokinetics.药代动力学的临床相关性。

Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001.

On the interaction between phenytoin and digoxin.关于苯妥英钠与地高辛之间的相互作用。

Eur J Clin Pharmacol. 1985;29(1):49-53. doi: 10.1007/BF00547368.

Acebutolol and oral surgery: plasma levels following a single oral dose.醋丁洛尔与口腔外科手术：单次口服剂量后的血浆水平

Ann R Coll Surg Engl. 1985 Mar;67(2):124-6.

The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.抗心律失常药物在妊娠和哺乳期的药代动力学。

Clin Pharmacokinet. 1987 Apr;12(4):253-91. doi: 10.2165/00003088-198712040-00002.

本文引用的文献

The present status of therapy of the cardiac arrhythmias with quinidine.奎尼丁治疗心律失常的现状

Am Heart J. 1951 Nov;42(5):771-97. doi: 10.1016/0002-8703(51)90184-6.

EFFECTS OF BETA-ADRENERGIC BLOCKADE WITH PROPRANOLOL IN PATIENTS WITH ATRIAL ARRHYTHMIAS.

N Engl J Med. 1965 Aug 19;273:410-5. doi: 10.1056/NEJM196508192730802.

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.与奎尼丁作为抗心律失常原型药物作用相关的一些细胞和代谢方面的考量

Am J Med. 1964 Nov;37:685-99. doi: 10.1016/0002-9343(64)90018-x.

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE.二苯乙内酰脲和苯巴比妥中毒。肝脏疾病的作用。

Arch Neurol. 1964 Dec;11:649-56. doi: 10.1001/archneur.1964.00460240081011.

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.二苯乙内酰脲的代谢、血药浓度及毒性

Arch Neurol. 1964 Dec;11:642-8. doi: 10.1001/archneur.1964.00460240074010.

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.羟化不足作为苯妥英钠毒性的一个原因

Neurology. 1964 Jun;14:542-8. doi: 10.1212/wnl.14.6.542.

Quinidine toxicity and its treatment. An Experimental study.奎尼丁毒性及其治疗。一项实验研究。

Am Heart J. 1963 Mar;65:340-8. doi: 10.1016/0002-8703(63)90008-5.

Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.影响慢性心房颤动转复的因素，特别提及血清奎尼丁浓度

Circulation. 1956 Oct;14(4 Part 1):568-83. doi: 10.1161/01.cir.14.4.568.

Dangerous consequence from use of phenytoin in atrial flutter.心房扑动时使用苯妥英钠的危险后果。

Br Med J. 1967 Oct 7;4(5570):34. doi: 10.1136/bmj.4.5570.34.

Some causes of ineffectiveness of diphenylhydantoin.苯妥英钠无效的一些原因。

Arch Neurol. 1966 May;14(5):489-92. doi: 10.1001/archneur.1966.00470110033004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验